AU Patent

AU2003216921B2 — Medicaments containing steroids and a novel anticholinesterase drug

Assigned to Boehringer Ingelheim Pharma GmbH and Co KG · Expires 2008-03-13 · 18y expired

What this patent protects

Patent listed against Tudorza Pressair.

Drugs covered by this patent

Tudorza Pressair (ACLIDINIUM BROMIDE) · Covis

Patent Metadata

Patent number: AU2003216921B2
Jurisdiction: AU
Classification: —
Expires: 2008-03-13
Drug substance claim: No
Drug product claim: No
Assignee: Boehringer Ingelheim Pharma GmbH and Co KG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.